Clinical Trial: Liver Cirrhosis Network Rosuvastatin Efficacy and Safety for Cirrhosis in the United States
Study Status: Completed
Recruit Status: RECRUITING
Condition: Cirrhosis
Study Type: INTERVENTIONAL
Official Title: Liver Cirrhosis Network (LCN) Rosuvastatin Efficacy and Safety for Cirrhosis in the United States (RESCU): A Double-Blind Randomized, Placebo-Controlled Phase 2 Study
Brief Summary:
This is a double-blind, phase 2 study to evaluate safety and efficacy of rosuvastatin in comparison to placebo after 2 years in patients with compensated cirrhosis.
Read more